devoted to determining and implementing the best ways
to prevent, diagnose and treat diseases in children
in an independent global collaboration that seeks to standardize
best practices across disease areas and populations
such as flexibility, commitment and transparency
to generate the scientific data necessary to market drugs
at doses that are safe and effective for children
so as to harness the body's response
to HIV and antiretrovirals
to ensure effective treatments are available
for common infections for generations to come
to make powerful informed decisions about their health
and healthcare and improve the quality of their lives
If you are fleeing the war in Ukraine and coming to the European Union, if you need medical assistance for your children and yourself, leave us a message and we will connect you with an HIV centre closest to you.
The methodology team at the MRC Clinical Trials Unit at UCL is a key partner of Penta and has made a huge contribution to our studies on HIV. The team recently published a paper in Sage Journals describing how the advantages of two designs can be practically combined: factorial designs, which do two or more…READ MORE
A large study on the effectiveness of the Pfizer-BioNTech’s Covid-19 vaccine in children aged 5-11 was published in The New England Journal of Medicine. The study was conducted at Israel’s largest healthcare organization, Clalit Health Services, in collaboration with researchers from the University of Padua, Harvard University and University College London. This is one of the…READ MORE
Through independent research into child health, Penta is one of the most prominent scientific organizations dedicated to children’s health. We are an alliance of people united by a common purpose: to improve prevention, diagnosis and treatment of infection in children.
Our global independent scientific network offers an incredible depth and breadth of expertise in the area of infections, including clinicians, researchers and healthcare professionals.
We leverage this diversity in conducting research, world class clinical trials and training programs. All with the aim to improve the lives of women and children through the generation and application of new scientific knowledge.
We are involved in research projects globally that operate along the scientific priorities: HIV & viral infection, severe sepsis and antimicrobial resistance, infection in pregnancy and neglected or emerging childhood infections. Our research embraces basic, pharmacological, clinical, social and population sciences.
We continue to build on our existing partnerships and seek out potential new collaborations to further our work.
The Penta ID Network continues to grow, bringing together patients and their care-givers worldwide to address a wide range of healthcare issues.
